Yuka Tsukamoto

Drug discontinuation after treatment with minimum maintenance dose of an antithyroid drug in Graves' disease: a retrospective study on effects of treatment duration with minimum maintenance dose on lasting remission

Toshiaki Konishi, Yasuyuki Okamoto, Miki Ueda et al. · Endocrine Journal · 2010 · 51 citations · Full text

Japan Thyroid Association, Thyroid Disease, Pharmacology +11

The ASK1-specific inhibitors K811 and K812 prolong survival in a mouse model of amyotrophic lateral sclerosis

Takao Fujisawa, M Takahashi, Yuka Tsukamoto et al. · Human Molecular Genetics · 2015 · 47 citations · Full text

Subcutaneous Panniculitislike Tcell Lymphoma: Successful Initial Treatment with Prednisolone and Cyclosporin A

Yuka Tsukamoto, Katsunobu Yoshioka, Yoko Omura et al. · Internal Medicine · 2006 · 37 citations · Full text

Immunology, Pathology, Cyclosporin A +16

Selegiline ameliorates depression-like behaviors in rodents and modulates hippocampal dopaminergic transmission and synaptic plasticity

Toshiko Ishikawa, Motoki Okano, Akiko Minami et al. · Behavioural Brain Research · 2018 · 26 citations · Full text

Synaptic Transmission, Psychopharmacology, Pharmacotherapy +20

A systematic immunoprecipitation approach reinforces the concept of common conformational alterations in amyotrophic lateral sclerosis-linked SOD1 mutants

Takao Fujisawa, Namiko Yamaguchi, Hisae Kadowaki et al. · Neurobiology of Disease · 2015 · 12 citations · Full text

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Systematic Immunoprecipitation Approach +6